PT-141 vs CJC-1295
Head-to-head comparison of PT-141 (Bremelanotide (Melanocortin Receptor Agonist)) and CJC-1295 (Growth Hormone Releasing Hormone Analog) — benefits, dosing, side effects, research data, and where to buy.
| Property | PT-141 | CJC-1295 |
|---|---|---|
| Category | Performance | Performance |
| Full Name | Bremelanotide (Melanocortin Receptor Agonist) | Growth Hormone Releasing Hormone Analog |
| Molecular Weight | 1,025.2 Da | 3,367.97 Da |
| Half-Life | ~2.7 hours | ~6-8 days (DAC) |
| Amino Acids | 7 | 30 |
| Typical Dose | 1.75 mg | 1-2 mg/week |
| Route | SC | SC |
| Purity | — | — |
| Studies Count | 178 | 167 |
| Research Status | FDA Approved | Clinical Trials |
PT-141 Benefits
- ✓Enhances sexual desire and arousal
- ✓Works through CNS (not vascular)
- ✓FDA-approved for HSDD
- ✓Effective for both men and women
- ✓Does not require sexual stimulation to work
CJC-1295 Benefits
- ✓Sustained GH release over days
- ✓Improved body composition
- ✓Enhanced deep sleep quality
- ✓Accelerated recovery from training
- ✓Increased protein synthesis
PT-141 Dosing
Standard: 1.75 mg SC, 45 min before activity|Max frequency: Once every 24 hours|Max: 8 doses per month|Men (off-label): 1-2 mg SC as needed
CJC-1295 Dosing
Without DAC: 100-200 mcg SC 2-3 times daily|With DAC: 1-2 mg SC once or twice weekly|Combined with Ipamorelin: 100 mcg each, 2-3x daily
PT-141 Side Effects
- ⚠Common: Nausea (40%), flushing, headache, injection site reactions
- ⚠Moderate: Elevated blood pressure (transient), fatigue
- ⚠Serious: Focal hyperpigmentation with repeated use
- ⚠Contraindications: Uncontrolled hypertension, cardiovascular disease
CJC-1295 Side Effects
- ⚠Common (Mild): Water retention, tingling/numbness, flushing
- ⚠Moderate: Joint stiffness, carpal tunnel-like symptoms
- ⚠Rare: Elevated blood sugar (transient)
Research Overview
PT-141
PT-141 has robust clinical evidence including multiple Phase III trials. FDA-approved in 2019. Unique mechanism of action through melanocortin-4 receptors in the brain. Well-characterized safety and efficacy profile.
CJC-1295
CJC-1295 has good pre-clinical and early clinical data. The DAC variant shows sustained GH elevation for days. Often combined with GHRPs for synergistic GH release.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.